“…Although stress‐ulcer prophylaxis is indicated for critical patients at high risk for UGIB, the use of these drugs can increase the likelihood of ventilator‐associated pneumonia (VAP) because of the increase in gastric bacterial colonisation, gastric reflux and subsequent micro‐aspiration into the lower respiratory tract . Despite progress in this area, the majority of issues relating to the management of VAP and its risk factors remain unresolved in clinical practice.…”